Company research / FMC

FMC Corp (FMC)

SEC name FMC CORP · CIK 0000037785 · NYSE · Chemicals & Allied Products

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, FMC Corp reported revenue of $3.47B. Revenue fell 18.3% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $3.25B.

Key ratios (year ended 2025-12-31)

37.0%
Gross margin
-47.0%
Operating margin
-64.6%
Net margin
-106.7%
Return on year-end equity
-18.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-16

Headquarters locality: BNY Mellon Center · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Stock splits: 2-for-1, first reflected in a filing dated 2012-08-01. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$3.25B$3.47B$4.25B$4.49B$5.80B$5.05B$4.64B$4.61B$4.29B$2.53B$2.54B
Cost of Revenue$2.10B$2.18B$2.60B$2.66B$3.48B$2.88B$2.60Bn/an/an/an/a
Gross Profit$1.15B$1.28B$1.65B$1.83B$2.33B$2.16B$2.05B$2.08B$1.88B$951.80M$931.20M
R&D Expense$256.90M$266.10M$278.00M$328.80M$314.20M$304.70M$287.90M$298.10M$287.70M$138.40M$134.50M
Operating Income-$2.01B-$1.63B$506.50M$555.60M$1.14B$1.03B$896.90M$821.60M$740.90M$158.50M$266.60M
Depreciation & Amortization$169.60M$173.60M$176.30M$184.30M$169.40M$170.90M$162.70M$150.10M$150.20M$97.80M$100.60M
EBITDA-$1.84B-$1.45B$682.80M$739.90M$1.31B$1.21B$1.06B$971.70M$891.10M$256.30M$367.20M
Net Income-$2.76B-$2.24B$341.10M$1.32B$736.50M$739.60M$552.40M$477.40M$502.10M$535.80M$209.10M
EPS (Diluted)n/a-$17.88$2.72$10.53$5.81$5.73$4.23$3.62$3.69$3.99$1.56
Total Assets$9.14B$9.69B$11.65B$11.93B$11.17B$10.67B$10.19B$9.87B$9.97B$9.21B$6.14B
Long-Term Debt$3.96B$3.36B$3.10B$3.12B$2.82B$2.82B$3.02B$3.11B$2.53B$3.09B$1.80B
Shareholders' Equity$1.66B$2.10B$4.51B$4.43B$3.40B$3.14B$3.08B$2.56B$3.21B$2.71B$1.99B
Cash & Equivalents$476.60M$584.50M$357.30M$302.40M$572.00M$516.80M$568.90M$339.10M$134.40M$283.00M$64.20M
Operating Cash Flow$235.00M-$6.20M$736.70M-$300.30M$660.00M$898.60M$736.80M$555.60M$362.70M$232.00M$368.90M
Capital Expenditures$71.60M$96.30M$67.90M$133.90M$142.30M$100.10M$67.20M$93.90M$83.00M$38.30M$91.20M
Free Cash Flow$163.40M-$102.50M$668.80M-$434.20M$517.70M$798.50M$669.60M$461.70M$279.70M$193.70M$277.70M
Share Repurchasesn/a$0$0$75.00M$100.00M$400.00M$50.00M$400.00M$200.00M$0$11.20M
Dividends Paid$166.00M$291.30M$290.60M$290.50M$267.50M$247.20M$228.50M$210.30M$89.20M$88.80M$88.60M
Dividends Per Sharen/a$1.82$2.32$2.32$2.17$1.96$1.80$1.64$0.90$0.66$0.66
Weighted Average Diluted Sharesn/a125.16M125.36M125.53M126.71M129.15M130.58M132.00M135.88M134.25M134.54M
EPS (Basic)n/a-$17.88$2.73$10.55$5.83$5.76$4.26$3.64$3.72$3.99$1.56

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView